Rare diseases
Investigational molecules
Locations
Back to Hungary123 clinical trials in Szolnok, Hungary. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study of AP31969 compared to placebo to control heart rhythm in patients with atrial fibrillation
HungaryStudy of raludotatug deruxtecan, ifinatamab deruxtecan and docetaxel in patients with previously treated stage IV squamous non-small cell lung cancer
HungaryStudy of ifinatamab deruxtecan, raludotatug deruxtecan and docetaxel in previously treated stage IV non-small cell lung cancer patients
HungaryStudy of Pembrolizumab and MK-2870 for Patients with Metastatic Squamous Non-small Cell Lung Cancer
HungaryStudy of Pembrolizumab, Vibostolimab, and Chemotherapy for Patients with Newly Diagnosed Resectable Stage II-IIIB Non-Small Cell Lung Cancer
HungaryStudy to Compare Datopotamab Deruxtecan with Rilvegostomig or Alone Against Pembrolizumab in Patients with Advanced Non-Small Cell Lung Cancer with High PD-L1 Levels
HungaryStudy on THIO and Cemiplimab for Patients with Advanced Non-Small Cell Lung Cancer
HungaryPrevention of Stroke and Systemic Embolism in Atrial Fibrillation Patients Treated with REGN7508 (cenvacibart) versus Apixaban
HungaryStudy comparing MB04 (etanercept biosimilar) with Enbrel in patients with moderate to severe rheumatoid arthritis who are taking methotrexate
HungaryStudy on the Effectiveness of JNJ-77242113 and Deucravacitinib for Treating Moderate to Severe Plaque Psoriasis in Adults
HungaryStudy of LY3454738 for Treating Moderate-to-Severe Atopic Dermatitis in Adults
HungaryHungaryThe busiest research cities in the country
What the registry says about research in the country
Extensive clinical trials focusing on plaque psoriasis and atopic dermatitis treatments, evaluating novel therapies for moderate to severe cases.
Multiple trials testing new biological treatments and long-term safety assessments for chronic skin conditions.
Comprehensive research into various cancer types, with particular focus on lung cancer treatments and innovative immunotherapy approaches.
Investigation of novel combination therapies and targeted treatments for advanced stage cancers.
Studies examining treatments for heart failure prevention and management of cardiovascular conditions.
Innovative approaches to reducing cardiovascular risks and improving patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
